🔗 Share this article

As the United States continues making sweeping changes to its immunization guidelines, a particular individual appears in a surprising turn: Tracy Beth Høeg, a Danish American physician and epidemiologist who first made her name by expressing skepticism about COVID-19 shots throughout the global health crisis and has focused upon alleged deaths following COVID-19 vaccination in her short time at the FDA.

Scheduled Changes to Childhood Immunization Schedule

Health officials were set to announce major revisions to the pediatric vaccine schedule in December, synchronizing the US with Denmark’s immunization schedule, sources say – a substantial departure that would put the US at odds with much of the world with no evidence for public health gain. The planned update has been postponed until the new year.

Instead of Vinay Prasad, Høeg is scheduled to speak at the event. She was just designated interim head of the FDA’s CDER, the fifth person to head the division this year.

Consolidating Power at the Regulatory Body

The acting appointment might represent a strengthened alliance between the pharmaceutical and vaccine divisions as Dr. Høeg and Prasad consolidate power at the FDA – and it signals a renewed priority upon rolling back long-standing vaccines at the FDA.

Dr. Høeg has repeatedly called for discontinuing some childhood vaccine recommendations in the US so as to align more similar to Denmark's approach, a nation with nationalized medicine and a citizenry approximately the population of the state of Wisconsin.

So far statements, she has kept her attention on vaccines – usually the domain of Prasad, director of the FDA’s Center for Biologics Evaluation and Research (CBER) – instead of drug regulation.

Doubts Over Expertise

Høeg has no obvious track record in medication creation, approval processes or administrative roles, which has been customary for former heads of the biologics center. She has served at the FDA as a key advisor to the FDA chief and CBER since spring.

“She doesn’t seem to have the requisite experience” for overseeing the drug-regulation department, said a neurologist and psychiatrist. “She lacks experience running a clinical trial. She has no expertise in leading a major agency. She lacks background in drug approvals.”

Previous commissioners of the center would “be deeply familiar with laws and regulations and the science of medication creation”, commented Dr. Janet Woodcock. “Clearly, she doesn’t have the sort of resume that prior appointees who headed CBER have had.”

The drug center has an enormous range of responsibilities at the agency, Woodcock emphasized.

“Many people just pays attention on the new drug program, but the generic program clears a multitude of generic drugs. There’s a biologic copycat branch, OTC medication office and more, and all of those must be managed,” Woodcock noted. “The thing you don’t keep your eye on, that is the part that I always told people is going to bite you.”

There is also, a major leadership component to the role, which supervises in excess of 5,000 staff members. “It’s a massive leadership role, if you execute it properly,” the former official concluded.

Official Statement and Contentious Policies

When asked about questions about Dr. Høeg's credentials and whether this selection represents greater collaboration among agency officials on vaccines, a representative said that the “inquiries rely on incorrect presumptions”.

“Her resume matches the duties of her position,” the official stated, noting the period Dr. Høeg spent advising the agency head on “drug safety and approval science, including computational safety modeling and shot safety tracking”.

In her interim role, Dr. Høeg inherits the commissioner’s new expedited review system, a disputed one-day drug-approval program that reportedly troubled her preceding directors. “How are these medications being chosen for this expedited pathway? Who makes the choices?” Dr. Howard asked. “There’s a lot of lack of transparency happening at the agency right now.”

Broadly speaking, he stated, “the FDA appears to be shifting towards laxer rules of all drugs, aside from vaccines.”

Public Track Record on Vaccines

Concerning vaccines, Dr. Høeg has a more documented, if troubling, history, Howard have noted. She released a study using non-validated public submissions to estimate the frequency of heart inflammation after Covid immunization. She counseled the Florida chief medical officer Dr. Joseph Ladapo, who was said to have modified findings to suggest COVID-19 vaccinations are riskier than they are.

Among her “desired changes” for the new administration featured altering regulations for recently developed shots and discontinuing “unnecessary” vaccines, she stated post-election on a online show. At the agency, Høeg has according to sources proposed preventing teenage boys from getting COVID-19 vaccinations.

“She is an complete true believer who commences with her beliefs and tailors the evidence to fit the science in a very disingenuous, fraudulent way,” Howard said.

Gaining Influence and a “Campaign of Retribution”

Høeg joined fellow dissenters, {like|